From: YKL-40 tissue expression and plasma levels in patients with ovarian cancer
Characteristic | YKL-40 protein expression (N = 473) | Plasma YKL-40 (μg/l) (N = 76) | ||
---|---|---|---|---|
N (%) | Median (range) | N (%) | Median (range) | |
FIGO stage: | ||||
I | 157 (33) | 10 (0–90) | 17 (22) | 59 (20–340) |
II | 48 (10) | 5 (0–30) | 4 (5) | 53 (39–259) |
III | 245 (52) | 10 (0–70) | 47 (62) | 168 (32–1808) |
IV | 23 (5) | 20 (5–40) | 8 (11) | 320 (86–2650) |
Histological type of tumor: | ||||
Undifferentiated carcinoma | 9 (2) | 20 (0–40) | 3 (4) | 576 (156–1808) |
Adenocarcinoma (NOS) | 23 (5) | 10 (0–30) | 5 (6) | 452 (237–2650) |
Serous adenocarcinoma | 249 (53) | 5 (0–70) | 50 (66) | 112 (20–548) |
Mucinous adenocarcinoma | 53 (11) | 10 (0–80) | 7 (9) | 102 (20–856) |
Endometroid adenocarcinoma | 69 (15) | 10 (0–90) | 8 (11) | 93 (29–193) |
Clear-cell neoplasm | 46 (10) | 10 (0–40) | 2 (3) | 220 (59–380) |
No information | - | - | 1 (1) | 340 |
Histological grade of tumor: | ||||
Grade 1 | 124 (26) | 10 (0–60) | 17 (22) | 61 (20–356) |
Grade 2 | 165 (35) | 10 (0–80) | 27 (36) | 162 (32–856) |
Grade 3 | 183 (39) | 10 (0–90) | 26 (34) | 144 (20–2650) |
No information | - | - | 6 (8) | 360 (29–1808) |